Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response

British Journal of Haematology

Volumn 119, Issue 2, 2002, Pages 445-453

  Cazzaniga, Giovanni ^a   Lanciotti, Marina ^b   Rossi, Vincenzo ^a   Di Martino, Daniela ^b   Aricò, Maurizio ^c   Valsecchi, Maria Grazia ^a   Basso, Giuseppe ^d   Masera, Giuseppe ^a   Micalizzi, Concetta ^b   Biondi, Andrea ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Ospedale dei Bambini G Di Cristina   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

Author keywords

BCR ABL; Childhood ALL; MRD; Ph+; t(9; 22)

Indexed keywords

ASPARAGINASE; BCR ABL PROTEIN; CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER MORTALITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; QUALITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT FAILURE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FUSION PROTEINS, BCR-ABL; HUMANS; INFANT; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; METHOTREXATE; NEOPLASM, RESIDUAL; PREDNISONE; PROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 18744382444     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03838.x     Document Type: Article

References (42)

1. Aricò, M., Valsecchi, M.G., Camitta, B., Schrappe, M., Chessells, J., Baruchel, A., Gaynon, P., Silverman, L., Janka-Schaub, G., Kamps, W., Pui, C.H. & Masera, G. (2000) Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia. New England Journal of Medicine, 342, 998-1006.
2. Aricò, M., Valsecchi, M.G., Conter, V., Rizzari, C., Pession, A., Messina, C., Barisone, E., Poggi, V., De Rossi, G., Locatelli, F., Micalizzi, M.C., Basso, G. & Masera, G. for the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) (2002) Improved outcome in high risk childhood Acute Lymphoblastic Leukemia defined by prednisone poor response treated with double BFM protocol II. Blood, 100, 420-426.
3. Balduzzi, A., Gooley, T., Anasetti, C., Sanders, J.E., Martin, P.J., Petersdorf, E.W., Appelbaum, F.R., Buckner, C.D., Matthews, D., Storb, R., Sullivan, K.M. & Hansen, J.A. (1995) Unrelated donor marrow transplantation in children. Blood, 86, 3247-3256.
4. Bassan, R., Rohatiner, A.Z., Rambaldi, A., Lerede, T., Di Bona, E., Carter, M., Rossi, G., Pogliani, E., Lambertenghi-Deliliers, G., Fabris, P., Porcellini, A., Lister, T.A. & Barbui, T. (1999) Clinical sensitivity to anthracyclines in Ph/BCR+ acute lymphoblastic leukemia. Advances in Experimental Medicine and Biology, 457, 489-499.
5. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A., Gralnick, H.R. & Sultan, C. (1981) The morphological classification of acute lymphoblastic leukaemia: Concordance among observers and clinical correlations. British Journal of Haematology, 47, 553-561.
6. Biondi, A., Valsecchi, M.G., Seriu, T., D'Aniello, E., Willemse, M.J., Fasching, K., Pannunzio, A., Gadner, H., Schrappe, M., Kamps, W.A., Bartram, C.R., van Dongen, J.J. & Panzer-Grumayer, E.R. (2000) Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia, 14, 1939-1943.
7. Brisco, M.J., Sykes, P.J., Dolman, G., Neoh, S.H., Hughes, E., Peng, L.M., Tauro, G., Ekert, H., Toogood, I., Bradstock, K. & Morley, A.A. (1997) Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia. Leukemia, 11, 1497-1500.
8. Chessells, J.M., Bailey, C. & Richards, S.M. (1995) Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X. Lancet, 345, 143-148.
9. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
10. Crist, W., Carroll, A., Shuster, J., Jackson, J., Head, D., Borowitz, M., Behm, F., Link, M., Steuber, P. & Ragab, A. (1990) Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood, 76, 489-494.
11. Deininger, M.W., Goldman, J.M. & Melo, J.V. (2000) The molecular biology of chronic myeloid leukemia. Blood, 96, 3343-3356.
12. van Dongen, J.J., Seriu, T., Panzer-Grumayer, E.R., Biondi, A., Pongers-Willemse, M.J., Corral, L., Stolz, F., Schrappe, M., Masera, G., Kamps, W.A., Gadner, H., van Wering, E.R., Ludwig, W.D., Basso, G., de Bruijn, M.A., Cazzaniga, G., Hettinger, K., van der Doesvan den Berg, A., Hop, W.C., Riehm, H. & Bartram, C.R. (1998) Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet, 352, 1731-1738.
13. van Dongen, J.J., Macintyre, E.A., Gabert, J.A., Delabesse, E., Rossi, V., Saglio, G., Gottardi, E., Rambaldi, A., Dotti, G., Griesinger, F., Parreira, A., Gameiro, P., Diaz, M.G., Malec, M., Langerak, A.W., San Miguel, J.F. & Biondi, A. (1999) Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia, 13, 1901-1928.
14. Druker, B.J., Sawyers, C.L., Kantarjian, H., Resta, D.J., Reese, S.F., Ford, J.M., Capdeville, R. & Talpaz, M. (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. New England Journal of Medicine, 344, 1038-1042.
15. Faderl, S., Kantarjian, H.M., Thomas, D.A., Cortes, J., Giles, F., Pierce, S., Albitar, M. & Estrov, Z. (2000) Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leukemia and Lymphoma, 36, 263-273.
16. Fletcher, J.A., Lynch, E.A., Kimball, V.M., Donnelly, M., Tantravahi, R. & Sallan, S.E. (1991) Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia. Blood, 77, 435-439.
17. Henze, G., Fengler, R., Hartmann, R., Kornhuber, B., Janka-Schaub, G., Niethammer, D. & Riehm, H. (1991) Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL REZ BFM 85). A relapse study of the BFM group. Blood, 78, 1166-1172.
18. Hongo, T., Yamada, S., Yajima, S., Watanabe, C., Fujii, Y., Kawasaki, H., Yazaki, M., Hanada, R. & Horikoshi, Y. (1999) Biological characteristics and prognostic value of in vitro three-drug resistance to prednisolone, L-asparaginase, and vincristine in childhood acute lymphoblastic leukemia. International Journal of Hematology, 70, 268-277.
19. Maurer, J., Janssen, J.W., Thiel, E., van Denderen, J., Ludwig, W.D., Aydemir, U., Heinze, B., Fonatsch, C., Harbott, J., Reiter, A., Riehm, H., Hoelzer, D. & Bartram, C.R. (1991) Detection of chimeric BCR/ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet, 337, 1055-1059.
20. Mitterbauer, G., Fodinger, M., Scherrer, R., Knobl, P., Jager, U., Laczika, K., Schwarzinger, I., Gaiger, A., Geissler, K., Greinix, H., Kalhs, P., Linkesch, W., Lechner, K. & Mannhalter, C. (1995) PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia. British Journal of Haematology, 89, 937-941.
21. Mitterbauer, G., Nemeth, P., Wacha, S., Cross, N.C., Schwarzinger, I., Jaeger, U., Geissler, K., Greinix, H.T., Kalhs, P., Lechner, K. & Mannhalter, C. (1999) Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction. British Journal of Haematology, 106, 634-643.
22. Miyamura, K., Tanimoto, M., Morishima, Y., Horibe, K., Yamamoto, K., Akatsuka, M., Kodera, Y., Kojima, S., Matsuyama, K., Hirabayashi, N., Yazaki, M., Imai, K., Onozawa, Y., Kanamaru, A., Mizutani, S. & Saito, H. (1992) Detection of Philadelphia chromosome-positive acute lymphoblastic leukemia by polymerase chain reaction: Possible eradication of minimal residual disease by marrow transplantation. Blood, 79, 1366-1370.
23. Munoz, L., Lopez, O., Martino, R., Brunet, S., Bellido, M., Rubiol, E., Sierra, J. & Nomdedeu, J.F. (2000) Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia. Haematologica, 85, 704-710.
24. Preudhomme, C., Henic, N., Cazin, B., Lai, J.L., Bertheas, M.F., Vanrumbeke, M., Lemoine, F., Jouet, J.P., Deconninck, E., Nelken, B., Cosson, A. & Fenaux, P. (1997) Good correlation between RT-PCR analysis and relapse in Philadelphia (Ph1)-positive acute lymphoblastic leukemia (ALL). Leukemia, 11, 294-298.
25. Pui, C.-H. & Evans, W.E. (1998) Acute lymphoblastic leukaemia. New England Journal of Medicine, 339, 605-615.
26. Putti, M.C., Rondelli, R., Cocito, M.G., Aricò, M., Sainati, L., Conter, V., Guglielmi, C., Cantù-Rajnoldi, A., Consolini, R., Pession, A., Zanesco, L., Masera, G., Biondi, A. & Basso, G. (1998) Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood, 92, 795-801.
27. Radich, J.P. (2001) Philadelphia chromosome-positive acute lymphocytic leukemia. Hematology/Oncology Clinics of North America, 15, 21-36.
28. Radich, J., Gehly, G., Lee, A., Avery, R., Bryant, E., Edmands, S., Gooley, T., Kessler, P., Kirk, J., Ladne, P., Thomas, E.D. & Appelbaum, F.R. (1997) Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation. Blood, 89, 2602-2609.
29. Rambaldi, A., Attuati, V., Bassan, R., Neonato, M.G., Viero, P., Battista, R., Di Bona, E., Rossi, G., Pogliani, E., Ruggeri, M., Amaru, R., Rivolta, A., Giudici, G., Biondi, A. & Barbui, T. (1996) Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia. Leukemia and Lymphoma, 21, 457-466.
30. Reiter, A., Schrappe, M., Ludwig, W.D., Hiddemann, W., Sauter, S., Henze, G., Zimmermann, M., Lampert, F., Havers, W., Niethammer, D., Odenwald, E., Ritter, J., Mann, G., Welte, K., Gadner, H. & Riehm, H. (1994) Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood, 84, 3122-3133.
31. van Rhee, F., Marks, D.I., Lin, F., Szydlo, R.M., Hochhaus, A., Treleaven, J., Delord, C., Cross, N.C. & Goldman, J.M. (1995) Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: Comparison of blood and bone marrow. Leukemia, 9, 329-335.
32. Ribeiro, R.C., Broniscer, A., Rivera, G.K., Hancock, M.L., Raimondi, S.C., Sandlund, J.T., Crist, W., Evans, W.E. & Pui, C.H. (1997) Philadelphia chromosome-positive acute lymphoblastic leukemia in children: Durable responses to chemotherapy associated with low initial white blood cell counts. Leukemia, 11, 1493-1496.
33. Roberts, W.M., Rivera, G.K., Raimondi, S.C., Santana, V.M., Sandlund, J.T., Crist, W.M. & Pui, C.H. (1994) Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet, 343, 331-332.
34. Saffroy, R., Lemoine, A., Brezillon, P., Frenoy, N., Delmas, B., Goldschmidt, E., Souleau, B., Nedellec, G. & Debuire, B. (2000) Real-time quantitation of bcr-abl transcripts in haematological malignancies. European Journal of Haematology, 65, 258-266.
35. Schlieben, S., Borkhardt, A., Reinisch, I., Ritterbach, J., Janssen, J.W., Ratei, R., Schrappe, M., Repp, R., Zimmermann, M., Kabisch, H., Janka-Schaub, G., Bartram, C.R., Ludwig, W.D., Riehm, H., Lampert, F. & Harbott, J. (1996) Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92. Leukemia, 10, 957-963.
36. Schrappe, M., Aricò, M., Harbott, J., Biondi, A., Zimmermann, M., Conter, V., Reiter, A., Valsecchi, M.G., Gadner, H., Basso, G., Bartram, C.R., Lampert, F., Riehm, H. & Masera, G. (1998) Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome. Blood, 92, 2730-2741.
37. Schrappe, M., Reiter, A., Ludwig, W.D., Harbott, J., Zimmermann, M., Hiddemann, W., Niemeyer, C., Henze, G., Feldges, A., Zintl, F., Kornhuber, B., Ritter, J., Welte, K., Gadner, H. & Riehm, H. (2000) Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood, 95, 3310-3322.
38. Secker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E. & Harrison, G. (1997) Cytogenetics adds independent prognostic information in adult acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party. British Journal of Haematology, 96, 601-610.
39. Stripecke, R., Skelton, D.C., Gruber, T., Afar, D., Pattengale, P.K., Witte, O.N. & Kohn, D.B. (1998) Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor. Human Gene Therapy, 9, 2049-2062.
40. Suryanarayan, K., Hunger, S.P., Kohler, S., Carroll, A.J., Crist, W., Link, M.P. & Cleary, M.L. (1991) Consistent involvement of the bcr gene by 9;22 breakpoints in pediatric acute leukemias. Blood, 77, 324-330.
41. Thomas, X., Thiebaut, A., Olteanu, N., Danaila, C., Charrin, C., Archimbaud, E. & Fiere, D. (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: Characteristics, prognostic factors and treatment outcome. Hematology and Cell Therapy, 40, 119-128.
42. Uckun, F.M., Nachman, J.B., Sather, H.N., Sensel, M.G., Kraft, P., Steinherz, P.G., Lange, B., Hutchinson, R., Reaman, G.H., Gaynon, P.S. & Heerema, N.A. (1998) Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukaemia in the context of contemporary intensive therapy. Cancer, 83, 2030-2039.